Jul 17, 2023, “HLA-DQA1*05 and upstream variants of PPARGC1B are associated with infliximab persistence in Japanese Crohn’s disease patients” has been published online in the Pharmacogenomics Journal.
Jul 17, 2023, “HLA-DQA1*05 and upstream variants of PPARGC1B are associated with infliximab persistence in Japanese Crohn’s disease patients” has been published online in the Pharmacogenomics Journal.